Business

Mass. Movers

Parexel moves higher on analyst upgrade

Josef H. von Rickenbach is the CEO of Parexel.
Essdras M Suarez/Globe Staff/File
Josef H. von Rickenbach is the CEO of Parexel.
Advertisement

Shares of Parexel International Corp. rose after the Waltham biopharmaceutical services company was upgraded by ISI Group from “neutral” to “buy” in a research note, according to TheFlyOnTheWall.com. The firm currently has a $57 price objective on the stock, up from $52.50. ISI Group’s target price indicates a potential upside of 14.73 percent from the stock’s previous close. In August, Parexel reported earnings per share of 50 cents for the quarter, beating estimates.